For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) was $41.90 for the day, up 3.94% from the previous closing price of $40.31. In other words, the price has increased by $3.94 from its previous closing price. On the day, 1.9 million shares were traded. CERE stock price reached its highest trading level at $41.92 during the session, while it also had its lowest trading level at $40.19.
Ratios:
Our analysis of CERE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.22 and its Current Ratio is at 10.22. In the meantime, Its Debt-to-Equity ratio is 0.85 whereas as Long-Term Debt/Eq ratio is at 0.85.
On September 28, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $33.Piper Sandler initiated its Overweight rating on September 28, 2023, with a $33 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 01 ’24 when COLES N ANTHONY sold 25,000 shares for $41.18 per share. The transaction valued at 1,029,535 led to the insider holds 25,928 shares of the business.
COLES N ANTHONY sold 50,000 shares of CERE for $2,030,520 on Jun 03 ’24. The Director now owns 15,638 shares after completing the transaction at $40.61 per share. On May 10 ’24, another insider, COLES N ANTHONY, who serves as the Director of the company, sold 50,000 shares for $42.10 each. As a result, the insider received 2,105,125 and left with 15,638 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CERE now has a Market Capitalization of 7633971200 and an Enterprise Value of 6980274176.
Stock Price History:
The Beta on a monthly basis for CERE is 1.40, which has changed by 0.3776487 over the last 52 weeks, in comparison to a change of 0.23279357 over the same period for the S&P500. Over the past 52 weeks, CERE has reached a high of $43.59, while it has fallen to a 52-week low of $19.59. The 50-Day Moving Average of the stock is 1.49%, while the 200-Day Moving Average is calculated to be 12.50%.
Shares Statistics:
CERE traded an average of 1.54M shares per day over the past three months and 2840170 shares per day over the past ten days. A total of 181.36M shares are outstanding, with a floating share count of 87.51M. Insiders hold about 51.97% of the company’s shares, while institutions hold 47.93% stake in the company. Shares short for CERE as of 1719532800 were 6588406 with a Short Ratio of 4.27, compared to 1717113600 on 7297771. Therefore, it implies a Short% of Shares Outstanding of 6588406 and a Short% of Float of 7.580000000000001.
